Searcharxiv⌕ Search

arXiv subjects

Yichen Lu

Publications and source records attributed to Yichen Lu.

21 records · Page 2Linked to original sources

Dive into the Resolution Augmentations and Metrics in Low Resolution Face Recognition: A Plain yet Effective New Baseline

Although deep learning has significantly improved Face Recognition (FR), dramatic performance deterioration may occur when processing Low Resolution (LR) faces. To alleviate this, approaches based on unified feature space are proposed with the sacrifice under High Resolution (HR) circumstances. To deal with the huge domain gap between HR and LR domains and achieve the best on both domains, we first took a closer look at the impacts of several resolution augmentations and then analyzed the difficulty of LR samples from the perspective of the model gradient produced by different resolution samples. Besides, we also find that the introduction of some resolutions could help the learning of lower resolutions. Based on these, we divide the LR samples into three difficulties according to the resolution and propose a more effective Multi-Resolution Augmentation. Then, due to the rapidly increasing domain gap as the resolution decreases, we carefully design a novel and effective metric loss based on a LogExp distance function that provides decent gradients to prevent oscillation near the convergence point or tolerance to small distance errors; it could also dynamically adjust the penalty for errors in different dimensions, allowing for more optimization of dimensions with large errors. Combining these two insights, our model could learn more general knowledge in a wide resolution range of images and balanced results can be achieved by our extremely simple framework. Moreover, the augmentations and metrics are the cornerstones of LRFR, so our method could be considered a new baseline for the LRFR task. Experiments on the LRFR datasets: SCface, XQLFW, and large-scale LRFR dataset: TinyFace demonstrate the effectiveness of our methods, while the degradation on HRFR datasets is significantly reduced.

cs.CV↗

Analysis of lane-change conflict between cars and trucks at merging section using UAV video data

The freeway on-ramp merging section is often identified as a crash-prone spot due to the high frequency of traffic conflicts. Very few traffic conflict analysis studies comprehensively consider different vehicle types at freeway merging section. Thus, the main objective of this study is to analyse conflicts between different vehicle types at freeway merging section. Field data are collected by Unmanned Aerial Vehicle (UAV) at merging areas in Shanghai, China. Vehicle extraction method is utilized to obtain vehicle trajectories. Time-to-collision (TTC) is utilized as the surrogate safety measure. TTC of car-car conflicts are the smallest while TTC of truck-truck conflicts are the largest. Traffic conflicts frequently occur at on-ramp and acceleration lane. Results show the spatial distribution of lane-change conflicts is significantly different between different vehicle types, suggesting that vehicle drivers should maintain safe distance especially car drivers. Besides, in order to decrease lane-change conflict at merging area, traffic management agencies are suggested to change dotted lie to solid lane at the beginning of acceleration lane.

cs.RO↗

The Future will be Different than Today: Model Evaluation Considerations when Developing Translational Clinical Biomarker

Finding translational biomarkers stands center stage of the future of personalized medicine in healthcare. We observed notable challenges in identifying robust biomarkers as some with great performance in one scenario often fail to perform well in new trials (e.g. different population, indications). With rapid development in the clinical trial world (e.g. assay, disease definition), new trials very likely differ from legacy ones in many perspectives and in development of biomarkers this heterogeneity should be considered. In response, we recommend considering building in the heterogeneity when evaluating biomarkers. In this paper, we present one evaluation strategy by using leave-one-study-out (LOSO) in place of conventional cross-validation (cv) methods to account for the potential heterogeneity across trials used for building and testing the biomarkers. To demonstrate the performance of K-fold vs LOSO cv in estimating the effect size of biomarkers, we leveraged data from clinical trials and simulation studies. In our assessment, LOSO cv provided a more objective estimate of the future performance. This conclusion remained true across different evaluation metrics and different statistical methods.

stat.AP↗